Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas
Yi An(Yale University), Zhong Chen(Fuzhou Second Hospital)
Cited by 4
Related Papers
NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.
|PubMed|2022|172
A signal network involving coactivated NF‐κB and STAT3 and altered p53 modulates BAX/BCL‐XL expression and promotes cell survival of head and neck squamous cell carcinomas
|International Journal of Cancer|2008|107
Proteomic Signatures of Epidermal Growth Factor Receptor and Survival Signal Pathways Correspond to Gefitinib Sensitivity in Head and Neck Cancer
|Clinical Cancer Research|2009|63
Alginate oligosaccharide alleviates myocardial reperfusion injury by inhibiting nitrative and oxidative stress and endoplasmic reticulum stress-mediated apoptosis
|Drug Design Development and Therapy|2017|50